Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Palfner-Wutte Nora Johanna |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2018
Originalarbeit (Zeitschrift)
** Niederkorn, A; Frühauf, J; Schwantzer, G; Wutte, N; Painsi, C; Werner, S; Stradner, M; Berghold, A; Hermann, J; Aberer, E
CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Arch Dermatol Res. 2018; 310(6):485-493
Doi: 10.1007/s00403-018-1836-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Fabian, E; Peck-Radosavljevic, M; Krones, E; Mueller, H; Lackner, C; Spreizer, C; Putz-Bankuti, C; Fuerst, W; Wutte, N; Fickert, P; Mischinger, H; Krejs, GJ
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 161: A 42-year-old journalist with fatigue, elevated liver function tests, hyperglycemia and pruritus.
Wien Klin Wochenschr. 2018; 130(17-18):545-556
Doi: 10.1007/s00508-018-1379-z
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Originalarbeit (Zeitschrift)
** Knobler, R; Moinzadeh, P; Hunzelmann, N; Kreuter, A; Cozzio, A; Mouthon, L; Cutolo, M; Rongioletti, F; Denton, CP; Rudnicka, L; Frasin, LA; Smith, V; Gabrielli, A; Aberer, E; Bagot, M; Bali, G; Bouaziz, J; Braae Olesen, A; Foeldvari, I; Frances, C; Jalili, A; Just, U; Kähäri, V; Kárpáti, S; Kofoed, K; Krasowska, D; Olszewska, M; Orteu, C; Panelius, J; Parodi, A; Petit, A; Quaglino, P; Ranki, A; Sanchez Schmidt, JM; Seneschal, J; Skrok, A; Sticherling, M; Sunderkötter, C; Taieb, A; Tanew, A; Wolf, P; Worm, M; Wutte, NJ; Krieg, T
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.
J Eur Acad Dermatol Venereol. 2017; 31(10):1581-1594
Doi: 10.1111/jdv.14466
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kovacs, G; Avian, A; Wutte, N; Hafner, F; Moazedi-Fürst, F; Kielhauser, S; Aberer, E; Brodmann, M; Graninger, W; Foris, V; Olschewski, A; Olschewski, H
Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.
Eur Respir J. 2017; 50(1):
Doi: 10.1183/13993003.01708-2016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Knobler, R; Moinzadeh, P; Hunzelmann, N; Kreuter, A; Cozzio, A; Mouthon, L; Cutolo, M; Rongioletti, F; Denton, CP; Rudnicka, L; Frasin, LA; Smith, V; Gabrielli, A; Aberer, E; Bagot, M; Bali, G; Bouaziz, J; Braae Olesen, A; Foeldvari, I; Frances, C; Jalili, A; Just, U; Kähäri, V; Kárpáti, S; Kofoed, K; Krasowska, D; Olszewska, M; Orteu, C; Panelius, J; Parodi, A; Petit, A; Quaglino, P; Ranki, A; Sanchez Schmidt, JM; Seneschal, J; Skrok, A; Sticherling, M; Sunderkötter, C; Taieb, A; Tanew, A; Wolf, P; Worm, M; Wutte, NJ; Krieg, T
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
J Eur Acad Dermatol Venereol. 2017; 31(9):1401-1424
Doi: 10.1111/jdv.14458
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bokanovic, D; Schrautzer, C; Schwarz, I; Laipold, K; Wutte, N; Aberer, W; Sturm, GJ
Is the skin prick test sufficient to diagnose vespid venom allergy?
ALLERGY. 2017; 72: 677-677.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 17-21, 2017; Helsinki, FINLAND.
[Poster]
Web of Science
2016
Originalarbeit (Zeitschrift)
** Pilch, M; Scharf, SN; Lukanz, M; Wutte, NJ; Fink-Puches, R; Glawischnig-Goschnik, M; Unterrainer, HF; Aberer, E
Spiritual well-being and coping in scleroderma, lupus erythematosus, and melanoma.
J Dtsch Dermatol Ges. 2016; 14(7):717-728
Doi: 10.1111/ddg.12715
Web of Science
PubMed
FullText
FullText_MUG
** Unterrainer, HF; Lukanz, M; Pilch, M; Scharf, S; Glawischnig-Goschnik, M; Wutte, N; Fink-Puches, R; Aberer, E
Spirituality and mood pathology in severe skin conditions: a prospective observational study.
Arch Dermatol Res. 2016; 308(7):521-525
Doi: 10.1007/s00403-016-1672-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Unterrainer, HF; Lukanz, M; Pilch, M; Scharf, S; Glawischnig-Goschnik, M; Wutte, N; Fink-Puches, R; Aberer, E
The influence of religious/spiritual well-being on quality of life in dermatological disease.
Br J Dermatol. 2016; 174(6):1380-1383
Doi: 10.1111/bjd.14359
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Bali, G; Frühauf, J; Wutte, N; Aberer, E
Cyclosporine Reduces Sclerosis in Morphea: A Retrospective Study in 12 Patients and a Literature Review.
Dermatology. 2016; 232(4):503-510
Doi: 10.1159/000448171
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klebes, M; Wutte, N; Aberer, E
Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature.
Dermatology. 2016; 232(1):91-96
Doi: 10.1159/000441054
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Wutte, N; El-Shabrawi-Caelen, L
Frontal hair loss and facial skin changes.
J Dtsch Dermatol Ges. 2015; 13(10):1040-1043
Doi: 10.1111/ddg.12700
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wutte, N; El-Shabrawi-Caelen, L
Frontal hair loss and facial skin changes].
J Dtsch Dermatol Ges. 2015; 13(10): 1040-1043.
Doi: 10.1111/ddg.120_12700
(- Case Report)
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bokanovic, D; Schwarz, I; Laipold, K; Smolle, C; Schrautzer, C; Wutte, N; Aberer, W; Sturm, GJ
Adherence to venom immunotherapy: when do we lose patients?
ALLERGY. 2015; 70: 313-313.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 06-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
2014
Originalarbeit (Zeitschrift)
** Bretterklieber, A; Painsi, C; Avian, A; Wutte, N; Aberer, E
Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.
BMC Res Notes. 2014; 7(3):594-594
Doi: 10.1186/1756-0500-7-594
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Wutte, N; Archelos, J; Crowe, BA; Zenz, W; Daghofer, E; Fazekas, F; Aberer, E
Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
J Neurol Sci. 2014; 347(1-2):96-103
Doi: 10.1016/j.jns.2014.09.027
Web of Science
PubMed
FullText
FullText_MUG
** Wutte, N; Palfner, M; Auer, H; Ruckenbauer, G; Valentin, T; Seeber, K; Aberer, W; Krause, R; Hoenigl, M
Toxocarosis and putative DRESS syndrome in an oncological patient: a case report.
Wien Klin Wochenschr. 2014; 126 Suppl 1(2):S51-S55
Doi: 10.1007/s00508-013-0444-x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Bokanovic, D; Schwarz, I; Wutte, N; Komericki, P; Aberer, W; Sturm, GJ
Specificity of conventional and Ves v 5-spiked venom decreases with increasing total IgE.
J Allergy Clin Immunol. 2014; 134(3):739-741
Doi: 10.1016/j.jaci.2014.03.038
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Aberer, E; Klebes, M; Wutte, N
Dapsone and retinoids
J INVEST DERMATOL. 2014; 134(5):1486-1486.-3rd International Conference on Cutaneous Lupus Erythematosus; MAY 06-08, 2013; Edinburgh, SCOTLAND.
[Oral Communication]
Web of Science
2013
Originalarbeit (Zeitschrift)
** Biazar, C; Sigges, J; Patsinakidis, N; Ruland, V; Amler, S; Bonsmann, G; Kuhn, A; EUSCLE co-authors
Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
Autoimmun Rev. 2013; 12(3): 444-454.
Doi: 10.1016/j.autrev.2012.08.019
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Wutte, N; Kovacs, G; Berghold, A; Reiter, H; Aberer, W; Aberer, E
CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis.
Br J Dermatol. 2013; 169(3):723-725
Doi: 10.1111/bjd.12411
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Sigges, J; Biazar, C; Landmann, A; Ruland, V; Patsinakidis, N; Amler, S; Bonsmann, G; Kuhn, A; EUSCLE Co-Authors
Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus.
Autoimmun Rev. 2013; 12(7): 694-702.
Doi: 10.1016/j.autrev.2012.10.005
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Aberer, E; Fingerle, V; Wutte, N; Fink-Puches, R; Cerroni, L
Within European margins.
Lancet. 2011; 377(9760): 178-178.
Doi: 10.1016/S0140-6736(10)62241-6
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wutte, N; Berghold, A; Krainberger, I; Aberer, E
Serum CXCL13 Chemokine is Not a Marker for Active Lyme Borreliosis.
Acta Derm Venereol. 2011; 91(6):724-725
Doi: 10.2340/00015555-1144
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wutte, N; Berghold, A; Löffler, S; Zenz, W; Daghofer, E; Krainberger, I; Kleinert, G; Aberer, E
CXCL13 chemokine in pediatric and adult neuroborreliosis.
Acta Neurol Scand. 2011; 124(5):321-328
Doi: 10.1111/j.1600-0404.2010.01477.x
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Wutte, N; Kovacs, G; Aberer, E
CXCL13-A PUTATIVE BIOMARKER IN SYSTEMIC SCLEROSIS
CLIN EXP RHEUMATOL. 2011; 29(1):38--International Conference on Controversies in Rheumatology and Autoimmunity; March 10-12, 2010; Florence, ITALY.
[Oral Communication]
Web of Science
News-Item
** Wutte, N; Fingerle, V; Fink-Puches, R; Cerroni, L; Aberer, E
B. afzelii - induced cutaneous Marginal Zone Lymphoma - A European Entity?
J DTSCH DERMATOL GES. 2011; 9: 254-255.
Web of Science